# Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients

Study · id `cardio:ct-nct04093336` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04093336](<https://clinicaltrials.gov/study/NCT04093336>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04093336

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04093336. Randomized; quadruple masking; primary purpose treatment. Start 2019-01-13 (actual); primary completion 2024-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04093336, source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)
- Started: 2019-01-13 (actual) (ClinicalTrials.gov record NCT04093336, source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)
- Primary completion: 2024-12-30 (anticipated) (ClinicalTrials.gov record NCT04093336, source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)
- Completion: 2024-12-30 (anticipated) (ClinicalTrials.gov record NCT04093336, source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04093336, source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04093336-2023-04-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients
- Condition: Infarction, Middle Cerebral Artery
- Condition: Infarction, Anterior Cerebral Artery
- Condition: Cerebral Infarction
- Condition: Stroke, Ischemic
- Condition: Acute Stroke
- Condition: Brain Infarction
- Condition: Infarction, PCA
- Condition: Infarction, Posterior Circulation, Brain
- Intervention (Biological): human umbilical cord mesenchymal stem cells
- Intervention (Biological): Placebo
- Intervention (Other): standardized treatment
- Lead sponsor: Shanghai East Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Shanghai East Hospital (`cardio:org-shanghai-east-hospital`)

## Provenance

Content hash: 983482e2537aa01cecbb22e5cc889b8d4c89da0be5ad094fbf6cb5c4ac2c0259
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
